TCM
Tang Capital Management’s Relmada Therapeutics RLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200,825
| Closed | -$104K | – | 205 |
|
|
2024
Q4 | $104K | Buy |
200,825
+150,000
| +295% | +$78K | 0.01% | 182 |
|
|
2024
Q3 | $165K | Sell |
50,825
-187,049
| -79% | -$606K | 0.01% | 150 |
|
|
2024
Q2 | $714K | Buy |
237,874
+237,492
| +62,171% | +$712K | 0.07% | 99 |
|
|
2024
Q1 | $1.78K | Buy |
+382
| New | +$1.78K | ﹤0.01% | 99 |
|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$349K | – | 119 |
|
|
2022
Q4 | $349K | Sell |
100,000
-300,000
| -75% | -$1.05M | 0.05% | 81 |
|
|
2022
Q3 | $14.8M | Hold |
400,000
| – | – | 1.82% | 18 |
|
|
2022
Q2 | $7.6M | Buy |
+400,000
| New | +$7.6M | 1.15% | 23 |
|
|
2022
Q1 | – | Sell |
-59,122
| Closed | -$1.33M | – | 53 |
|
|
2021
Q4 | $1.33M | Sell |
59,122
-40,878
| -41% | -$921K | 0.27% | 28 |
|
|
2021
Q3 | $2.62M | Hold |
100,000
| – | – | 0.54% | 18 |
|
|
2021
Q2 | $3.2M | Sell |
100,000
-100,000
| -50% | -$3.2M | 0.64% | 15 |
|
|
2021
Q1 | $7.04M | Hold |
200,000
| – | – | 1.98% | 8 |
|
|
2020
Q4 | $6.41M | Sell |
200,000
-300,000
| -60% | -$9.62M | 0.98% | 8 |
|
|
2020
Q3 | $18.8M | Hold |
500,000
| – | – | 3.4% | 8 |
|
|
2020
Q2 | $22.4M | Sell |
500,000
-800,000
| -62% | -$35.8M | 2.18% | 9 |
|
|
2020
Q1 | $44.3M | Hold |
1,300,000
| – | – | 6.23% | 2 |
|
|
2019
Q4 | $50.7M | Buy |
+1,300,000
| New | +$50.7M | 6.06% | 4 |
|